UW’s Institute for Protein Design spinout raises $100M for vaccine development
April 07, 2021 at 17:54 PM EDT
The biotech makes vaccines using “self-assembling” virus-like particle technology to treat life-threatening respiratory diseases. It will use the funding to advance its vaccine candidates into clinical trials.
